| Ytd | -34.61% | |
| 1y | -93.20% |
| Open | 3.11 | Prev Close | 3.11 | Low | 3.05 | High | 3.11 | Mkt Cap | 59.15K |
| Vol | 14.62K | Avg Vol | 206.61K | EPS | -393.10 | P/E | -0.01 | Forward P/E | N/A |
| Beta | 1.67 | Short Ratio | 0.08 | Inst. Own | 37.09% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 3.63 | 200-d Avg | 33.18 | 1yr Est | 0.00 |
Psyence BioMed Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceu
LaCorium AcquisitionThe Company today is also announcing a definitive agreement to acquire LaCorium
https://www.hhs.gov/press-room/fda-accelerates-action-treatments-serious-mental-illness-following-ex
Psyence Biomedical faces a double-digit decline Tuesday as traders lock in gains following a massive
Psyence Biomedical stock faces profit-taking on Tuesday after a massive rally fueled by a Trump exec
Psyence Biomedical (NASDAQ: PBM) stock is surging Monday on a broad psychedelic rally and a company-
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical
TopBuild Corp (NYSE: BLD) rises in pre-market trading after QXO (NYSE: QXO) agrees to acquire for $1
US stocks rise, Dow gains 600 points. NASDAQ up 1.05% and S&P 500 up 0.74%. Energy stocks down 4
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a clinical
Blaize Holdings rose 24.3% in pre-market trading on $50M contract with NeoTensr & MOU with Winma
https://www.cbsnews.com/news/psychedelic-drug-ibogaine-ptsd-trump-to-sign-executive-order/
syence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharma
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharm
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), today anno
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), today anno
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharm
NKE: -10% | Nike shares are trading lower. The company reported a 17% decline in Greater China sales
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharm
Psyence BioMed (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharmaceutical
Psyence Biomedical Ltd. (NASDAQ:PBM) ("Psyence BioMed" or the "Company"), a biopharm